The Houston-based cancer center is collaborating with Axiom Space, BioServe Space Technologies, Deep Space Biology and Mongoose Bio on the project, which will analyze how prolonged exposure to microgravity affects cell differentiation, activation, memory and exhaustion, according to a July 31 news release.
Upon return to Earth, the cryopreserved samples will be analyzed using single-cell sequencing. The goal is to scale any potential discoveries into therapeutic strategies that can improve cellular therapies.
The project is one of five being funded by the International Space Station National Laboratory and NASA. The two organizations are providing more than $7 million in inaugural funding for the cancer studies.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
